Purpose
To provide support for laboratory studies to determine if the addition of the HIV Tat antigen will a provide potential benefit for inclusion in an HIV vaccine
Grantee
Division
Global Health
Date
MAY 2025
Region served
GLOBAL
Committed amount
$1,226,415
Grant topic
HIV
Duration (months)
48
Grantee location
Roma, Italy
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.